PRRT2 and acute myeloid leukemia: The synergistic interaction between HXR9 and PKC-mediated signaling is particularly noteworthy, as it points to possible combinatorial approaches when targeting AML using HOX/PBX inhibitors, and indeed this was supported by results obtained using a murine model.